We are thrilled to share the success of EUCAIM’s participation at the European Congress of Radiology 2025! This year’s congress was a fantastic opportunity to
The EUropean Federation for CAncer Images (EUCAIM) project and the Australian National Imaging Facility have signed an international agreement to coordinate best practices for providing
Just in time for ECR 2025, we are excited to announce the publication of our latest paper: Empowering cancer research in Europe: the EUCAIM cancer
Catch EUCAIM in action at ECR 2025! Our experts will be presenting at the EIBIR booth, showcasing tools at the Pixel Pandemonium Exhibition as well
EUCAIM showcased its achievements to date to stakeholders from research, innovation, healthcare, and the public sector on the occasion the 2-year anniversary of the European
Today, the EUCAIM Consortium gathered in Brussels and online for its third consortium meeting, bringing together partners to discuss the project’s progress and next steps.
We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.
Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.
Apply by 10 June 2024!
We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.
EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.
Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.
Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.